<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7016157</article-id><article-id pub-id-type="pmc">2010639</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bleehen</surname><given-names>N. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Wiltshire</surname><given-names>C. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Plowman</surname><given-names>P. N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Watson</surname><given-names>J. V.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gleave</surname><given-names>J. R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Holmes</surname><given-names>A. E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lewin</surname><given-names>W. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Treip</surname><given-names>C. S.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hawkins</surname><given-names>T. D.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>4</month><year>1981</year></pub-date><volume>43</volume><issue>4</issue><fpage>436</fpage><lpage>442</lpage><abstract><p>The results are reported of a small clinical trial carried out to assess the potential value of the hypoxic cell radiosensitizer misonidazole in the radiation treatment of Grade 3 and 4 supratentorial astrocytomas. A total of 55 patients were randomly allocated to one of 3 treatment groups. No significant differences were seen between the median survivals of patients in the 2 control radiation groups and that of the third group in which oral misonidazole at a dose of 3 g/m2 preceded each of 4 weekly radiation doses. Possible reasons why no improvement was seen are discussed in detail.</p></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00451-0021.tif" xlink:title="scanned-page" xlink:role="436" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0022.tif" xlink:title="scanned-page" xlink:role="437" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0023.tif" xlink:title="scanned-page" xlink:role="438" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0024.tif" xlink:title="scanned-page" xlink:role="439" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0025.tif" xlink:title="scanned-page" xlink:role="440" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0026.tif" xlink:title="scanned-page" xlink:role="441" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00451-0027.tif" xlink:title="scanned-page" xlink:role="442" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

